These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2429934)
1. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72). Klug TL; Sattler MA; Colcher D; Schlom J Int J Cancer; 1986 Nov; 38(5):661-9. PubMed ID: 2429934 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Klug TL; Bast RC; Niloff JM; Knapp RC; Zurawski VR Cancer Res; 1984 Mar; 44(3):1048-53. PubMed ID: 6198078 [TBL] [Abstract][Full Text] [Related]
3. Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank. Ritts RE; Del Villano BC; Go VL; Herberman RB; Klug TL; Zurawski VR Int J Cancer; 1984 Mar; 33(3):339-45. PubMed ID: 6199316 [TBL] [Abstract][Full Text] [Related]
4. A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG-72) using monoclonal antibody B72.3. Paterson AJ; Schlom J; Sears HF; Bennett J; Colcher D Int J Cancer; 1986 May; 37(5):659-66. PubMed ID: 3699929 [TBL] [Abstract][Full Text] [Related]
5. Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants. Herlyn M; Shen JW; Sears HF; Civin CI; Verrill HL; Goldberg EM; Koprowski H Clin Exp Immunol; 1984 Jan; 55(1):23-35. PubMed ID: 6198117 [TBL] [Abstract][Full Text] [Related]
6. CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients. Gero EJ; Colcher D; Ferroni P; Melsheimer R; Giani S; Schlom J; Kaplan P J Clin Lab Anal; 1989; 3(6):360-9. PubMed ID: 2614571 [TBL] [Abstract][Full Text] [Related]
7. Sandwich radioimmunometric assay with murine monoclonal antibody, NCC-ST-439, for serological diagnosis of human cancers. Sugano K; Ohkura H; Maruyama T; Watanabe M; Hirohashi S; Shimosato Y; Kodaira S; Abe O Jpn J Cancer Res; 1988 May; 79(5):618-25. PubMed ID: 3136114 [TBL] [Abstract][Full Text] [Related]
8. Significance of measurement of a carbohydrate antigenic determinant 19-9 (CA 19-9) for monitoring colorectal cancer patients. Tomoda H; Furusawa M Jpn J Surg; 1986 Jan; 16(1):73-5. PubMed ID: 2421035 [TBL] [Abstract][Full Text] [Related]
9. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients. Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734 [TBL] [Abstract][Full Text] [Related]
10. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker. Bray KR; Koda JE; Gaur PK Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335 [TBL] [Abstract][Full Text] [Related]
11. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen. Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729 [TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity in detecting tumor-associated antigens in sera of patients with colorectal carcinoma. Herlyn M; Sears HF; Verrill H; Koprowski H J Immunol Methods; 1984 Dec; 75(1):15-21. PubMed ID: 6512262 [TBL] [Abstract][Full Text] [Related]
13. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4]. Ohuchi N; Takahashi K; Matoba N; Mori S Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074 [TBL] [Abstract][Full Text] [Related]
14. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer. Pant KD; Shochat D; Nelson MO; Goldenberg DM Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498 [TBL] [Abstract][Full Text] [Related]
15. Coexpression of different antigenic markers on moieties that bear CA 125 determinants. Yu YH; Schlossman DM; Harrison CL; Rhinehardt-Clark A; Soper JT; Klug TL; Zurawski VR; Bast RC Cancer Res; 1991 Jan; 51(2):468-75. PubMed ID: 1702359 [TBL] [Abstract][Full Text] [Related]
16. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients. Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823 [TBL] [Abstract][Full Text] [Related]
17. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392 [TBL] [Abstract][Full Text] [Related]
18. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay. Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871 [TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity in athymic mice of the human colon carcinoma cell line SW1116 expressing the tumor-associated antigenic determinant CA 19-9. Klug TL; Salzman S; Quinn A; Melincoff GA; Sedmak DD; Tubbs RR; Zurawski VR Cancer Res; 1984 Nov; 44(11):5212-8. PubMed ID: 6207914 [TBL] [Abstract][Full Text] [Related]
20. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]